Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Oct;31(5):559-562.
doi: 10.5021/ad.2019.31.5.559. Epub 2019 Aug 30.

Syringocystadenocarcinoma Papilliferum: A Case Report and Review of the Literature

Affiliations
Case Reports

Syringocystadenocarcinoma Papilliferum: A Case Report and Review of the Literature

Kyoung Geun Lee et al. Ann Dermatol. 2019 Oct.

Abstract

Syringocystadenocarcinoma papilliferum (SCACP) is a rare malignant adnexal neoplasm, which is considered as a malignant counterpart of syringocystadenoma papilliferum (SCAP). Clinically, SCACP appears as a nodule, inflammatory plaque, or tumor. The lesion is usually covered with crusts, which are formed by secretion of the apocrine epithelial cells. Histologically, SCACP resembles SCAP, with cystic papillomatous invaginations connected to the skin surface by funnel-shaped structures lined by infundibular epithelium. The stroma of the tumor consists of a dense inflammatory infiltrate of plasma cells and lymphocytes. SCACP differs from SCAP in terms of the architectural and cytological features of the tumor cells, and is characterized by higher nuclear cytoplasmic ratio, nuclear irregularity, coarse chromatin, and increased mitotic activity. However, the immunohistochemical findings of SCACP vary. Since only 49 cases of SCACP have been reported in the English literature, the clinical and histologic characteristics of SCACP have not been fully established. Further studies on the diagnostic criteria for SCACP are warranted. Here, we report a rare case of SCACP and present a review of other relevant literature.

Keywords: Sweat gland neoplasm; Syringocystadenocarcinoma papilliferum; Syringocystadenoma papilliferum.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. Exophytic erythematous outgrowing plaque on perianal area.
Fig. 2
Fig. 2. Biopsy from perianal area. (A) Tumor shows tubular and cystic configuration (H&E, ×40). (B) Wall of cystic structure shows papillomatous projections into cavity (H&E, ×100). (C) Tumor cells forming tubular structures show pale cytoplasm and large atypical nucleus with atypical mitoses. Stroma of papillae contains plasma cells and lymphocytes (H&E, ×400). (D) Tumor cells in epidermis show pagetoid spreads (H&E, ×400).

References

    1. Park SH, Shin YM, Shin DH, Choi JS, Kim KH. Syringocystadenocarcinoma papilliferum: a case report. J Korean Med Sci. 2007;22:762–765. - PMC - PubMed
    1. Numata M, Hosoe S, Itoh N, Munakata Y, Hayashi S, Maruyama Y. Syringadenocarcinoma papilliferum. J Cutan Pathol. 1985;12:3–7. - PubMed
    1. Chen J, Beg M, Chen S. Syringocystadenocarcinoma papilliferum in situ, a variant of cutaneous adenocarcinoma in situ: a case report with literature review. Am J Dermatopathol. 2016;38:762–765. - PubMed
    1. Parekh V, Guerrero CE, Knapp CF, Elmets CA, McKay KM. A histological snapshot of hypothetical multistep progression from nevus sebaceus to invasive syringocystadenocarcinoma papilliferum. Am J Dermatopathol. 2016;38:56–62. - PubMed
    1. Leeborg N, Thompson M, Rossmiller S, Gross N, White C, Gatter K. Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: case report and review of the literature. Arch Pathol Lab Med. 2010;134:1205–1209. - PubMed

Publication types